Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.
about
Incretin-Based Therapies for Diabetic Complications: Basic Mechanisms and Clinical EvidenceIncretin-Based Therapy for Prevention of Diabetic Vascular ComplicationsGLP-1-based strategies: a physiological analysis of differential mode of actionIndirect effects of glucagon-like peptide-1 receptor agonist exendin-4 on the peripheral circadian clocks in miceExenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in RatsCognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline?Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas.Anti-inflammatory effects of exendin-4, a glucagon-like peptide-1 analog, on human peripheral lymphocytes in patients with type 2 diabetes.Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injuryContribution of hyperglycemia on diabetic complications in obese type 2 diabetic SDT fatty rats: effects of SGLT inhibitor phlorizinDrugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis.Metanx alleviates multiple manifestations of peripheral neuropathy and increases intraepidermal nerve fiber density in Zucker diabetic fatty rats.Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disordersEffects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized studyProtection of trigonelline on experimental diabetic peripheral neuropathy.Effect of Exendin-4 on Autophagy Clearance in Beta Cell of Rats with Tacrolimus-induced Diabetes Mellitus.Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection.GLP-1 effects on islets: hormonal, neuronal, or paracrine?The extra-pancreatic effects of GLP-1 receptor agonists: a focus on the cardiovascular, gastrointestinal and central nervous systems.Extra-pancreatic effects of incretin-based therapies.Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.Impaired Axonal Regeneration in Diabetes. Perspective on the Underlying Mechanism from In Vivo and In Vitro Experimental Studies.Sensory and motor physiological functions are impaired in gastric inhibitory polypeptide receptor-deficient mice.Efficacy of glucagon-like peptide-1 mimetics for neural regeneration.Characterisation of pain responses in the high fat diet/streptozotocin model of diabetes and the analgesic effects of antidiabetic treatments.Transplantation of dental pulp stem cells improves long-term diabetic polyneuropathy together with improvement of nerve morphometrical evaluation.Glucagon-like peptide 1, insulin, sensory neurons, and diabetic neuropathy.The dipeptidyl peptidase IV inhibitor vildagliptin suppresses development of neuropathy in diabetic rodents: Effects on peripheral sensory nerve function, structure and molecular changes.Neurotrophic and neuroprotective properties of exendin-4 in adult rat dorsal root ganglion neurons: involvement of insulin and RhoA.Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons.
P2860
Q26739999-A7D34F07-B4B8-4C09-82D5-BDC10AB112FFQ26765470-9D858856-970C-4857-892E-27C05BAE07CFQ26997149-E4972CA1-EA0F-4406-AE20-68F77FDA847BQ27301386-BB9EDD29-ED99-4B66-8FB3-7D6EFDBFDEC8Q28550675-446E0A66-34EF-4F39-BFE3-56F4E4F2F472Q33603286-879802FE-3E02-483F-9D53-B82B5F54B0FDQ33603384-A2317946-3555-4BD8-B0EA-323B53909AD5Q33607642-D072B21B-D056-4B35-91A9-1165BB32CAC7Q34362412-150BED0B-F1BA-46B5-83CA-5869B7C0D401Q35594390-F271E96E-4134-4685-8118-083EA3EF6FC6Q35960169-F9DEF4B3-1323-4F95-9FAB-DD76D3AAEE49Q36109233-0A99FB25-F687-4689-A701-7ED1884A3E98Q36166654-94B23543-C04F-4272-B8E9-472D19CCC1DDQ36307536-06AC27E7-9C86-4EE7-B8BA-9FAB473B3E65Q36477770-2F585F22-B118-46CE-87C4-078EDDBF4999Q37111103-C139EA78-7A4A-45A2-809C-D11F5BBD7BCEQ38039489-19101933-6AE4-45D8-9748-FB76F8CE03CAQ38123791-DB954E1C-369D-4118-9D4A-0423EBE2DA6DQ38174279-5064A052-53A9-4E74-8316-5756BA6C7C44Q38194069-24F40338-9C1A-4641-AE55-DE4848E3274EQ38403431-20F38D0A-B73E-4DB7-8685-E9600C40AAC6Q38756949-139245AA-7157-41DB-9F77-149F6877B198Q39719357-EAB53627-7595-4FE9-B349-531CFE8FA860Q41983493-429DDE72-67EF-4E7F-AA2A-B6A2481A276AQ43159888-940CAAC6-F425-41DB-9DEE-6DD60CDD68EEQ47159384-DB145A64-EE97-4BF4-8DC8-9EF55AA4EA2CQ48511577-DE4EC017-6C36-4B74-82FE-686461A514A2Q48713671-2B8C861D-3382-4516-BA7C-444DF3099B52Q53486609-F5849473-2696-4372-ABBB-3A40796DAB3EQ55004136-50C95A93-38B2-494C-AAD2-66D2968A6548
P2860
Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.
@ast
Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.
@en
type
label
Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.
@ast
Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.
@en
prefLabel
Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.
@ast
Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.
@en
P2093
P2860
P356
P1433
P1476
Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.
@en
P2093
Ayako Fukami
Hideki Kamiya
Jiro Nakamura
Keiko Naruse
Masaki Kondo
Nobuaki Ozaki
Nobuya Inagaki
Norio Harada
Taiga Shibata
P2860
P304
P356
10.2337/DB10-1462
P407
P577
2011-08-01T00:00:00Z